Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ADC Therapeutics (ADCT) Tax Rate (2019 - 2025)

ADC Therapeutics has reported Tax Rate over the past 7 years, most recently at 2.26% for Q2 2025.

  • Quarterly results put Tax Rate at 2.26% for Q2 2025, down 161.0% from a year ago — trailing twelve months through Mar 2026 was 0.85% (down 42.0% YoY), and the annual figure for FY2022 was 0.74%, up 928.0%.
  • Tax Rate reached 2.26% in Q2 2025 per ADCT's latest filing, down from 0.43% in the prior quarter.
  • Across five years, Tax Rate topped out at 19.65% in Q4 2022 and bottomed at 911.2% in Q4 2021.
  • Median Tax Rate over the past 5 years was 0.43% (2025), compared with a mean of 55.99%.
  • The largest annual shift saw Tax Rate tumbled -91143bps in 2021 before it skyrocketed 93085bps in 2022.
  • Over 5 years, Tax Rate stood at 911.2% in 2021, then surged by 102bps to 19.65% in 2022, then tumbled by -99bps to 0.19% in 2023, then crashed by -210bps to 0.21% in 2024, then plummeted by -997bps to 2.26% in 2025.
  • Business Quant data shows Tax Rate for ADCT at 2.26% in Q2 2025, 0.43% in Q1 2025, and 0.21% in Q3 2024.